FDA approves gene therapy to fix mutations that can lead to blindness – Los Angeles Times
Los Angeles Times |
FDA approves gene therapy to fix mutations that can lead to blindness
Los Angeles Times Tuesday's announcement marks the third time in five months that the drug safety agency has allowed a gene therapy — a form of treatment with a long and fitful safety history — on the U.S. market. The first approval went to Kymriah, which treats a … After Decades, A Gene Therapy Is Approved. Next: The Debate On Price Gene therapy for rare form of blindness wins US approval – ABC News FDA Approves First Gene Therapy Targeting Rare Form of Inherited Blindness |
